Zhou Zhongmin, Penn Marc S, Forudi Farhad, Zhou Xiaorong, Tarakji Khaldoun, Topol Eric J, Lincoff A Michael, Wang Kai
Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
Arterioscler Thromb Vasc Biol. 2002 Oct 1;22(10):1598-603. doi: 10.1161/01.atv.0000032676.20514.8f.
P-selectin-mediated leukocyte-endothelium and leukocyte-platelet interaction has been reported after vascular injury and has been correlated with neointimal hyperplasia, but its role in neointimal formation after arterial injury in diabetes has not been described.
Using a Zucker diabetic rat balloon injury model, we examined the role of P-selectin in the vascular inflammatory process and neointimal formation after balloon injury. Immunohistochemistry revealed that P-selectin was intensely expressed and that CD45-positive leukocyte infiltration was significantly increased after arterial injury. A single preprocedural intravenous administration of a recombinant P-selectin-soluble glycoprotein ligand-Ig inhibited CD45-positive leukocyte accumulation and suppressed neointimal formation in the Zucker diabetic rat model.
These results suggest that reduction of P-selectin-mediated leukocyte activation with the use of recombinant P-selectin-soluble glycoprotein ligand-Ig decreases the inflammatory response and limits neointimal formation after balloon injury in diabetes.
血管损伤后已报道有P选择素介导的白细胞与内皮细胞及白细胞与血小板的相互作用,且与内膜增生相关,但P选择素在糖尿病动脉损伤后内膜形成中的作用尚未见描述。
利用Zucker糖尿病大鼠球囊损伤模型,我们研究了P选择素在球囊损伤后血管炎症过程及内膜形成中的作用。免疫组化显示,动脉损伤后P选择素强烈表达,且CD45阳性白细胞浸润显著增加。在Zucker糖尿病大鼠模型中,术前单次静脉注射重组P选择素可溶性糖蛋白配体-Ig可抑制CD45阳性白细胞聚集并抑制内膜形成。
这些结果表明,使用重组P选择素可溶性糖蛋白配体-Ig减少P选择素介导的白细胞活化可降低炎症反应并限制糖尿病球囊损伤后的内膜形成。